Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666445 · ClinicalTrials.gov registry record
Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test
A clinical trial, sponsored by Orasi Medical.
- Completed
- Registry status
- 150
- Enrollment target
NCT00666445: Completed study, sponsored by Orasi Medical.
NCT00666445 is a clinical trial that has completed, run by Orasi Medical. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00666445 has completed, sponsored by Orasi Medical.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This study is designed to test the hypothesis that the Synchronous Neural Interaction™ Test is useful for diagnosing Probable Alzheimer's Disease according to standard criteria. Subjects diagnosed with Alzheimer's Disease as well as age-matched normal control subjects will be evaluated for symptoms of Alzheimer's Disease and those meeting inclusion criteria will undergo a brief, non-invasive scan of brain function using a magnetoencephalography (MEG). The scan itself lasts 1 minute while the subject is asked to stare at a dot projected in front of them on a video screen. Orasi Medical believes that patterns of brain activity measured at rest are indicative of Alzheimer's Disease pathology. The protocol is amended to add a follow-up assessment for previously enrolled and completed subjects who agree to participate in the follow-up assessment approximately 9 - 15 months after initial study enrollment. Subjects who agree to participate in the follow-up assessment will undergo the same standardized tests and MEG scan procedure as completed in the initial study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00666445
The ClinicalTrials.gov registry entry for NCT00666445 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Orasi Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00666445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00666445 about?
NCT00666445 is a clinical study titled "Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test". This study is designed to test the hypothesis that the Synchronous Neural Interaction™ Test is useful for diagnosing Probable Alzheimer's Disease according to standard criteria. Subjects diagnosed with Alzheimer's Disease as well as age-matched normal control subjects will be evaluated for symptoms ...
What is the current status of trial NCT00666445?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2008-04. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00666445?
This trial is sponsored by Orasi Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.